首页
订购/客服:400-666-5481

Blarcamesine

    
≥98%

AVex-73;AE-37

源叶(MedMol)
S89001 一键复制产品信息
195615-83-9
C19H23NO
281.39202
AE-37; AVex-73; Anavex-2-73; Anavex-273; AE37; AVex73; Anavex273; AE 37; AVex 73; Anavex 2 73; Anavex 273; Blarcamesine
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89001-5mg
≥98%

¥610.00

货期:3-5天 - - - -
S89001-25mg
≥98%

¥1730.00

货期:3-5天 - - - -
S89001-100mg
≥98%

¥4530.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Blarcamesine (Anavex 2-73 free base) is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome
靶点: Sigma 1 Receptor;AChR
体内研究: Blarcamesine (10 mg/kg, 30 mg/kg; p.o.; daily; for 6.5 weeks) ameliorates motor deficits in Mecp2 HET mice with chronic administration. Blarcamesine ameliorates acoustic startle deficit in Mecp2 HET mice. Blarcamesine reverses deficits in visual acuity in older Mecp2 HET mice using the optokinetic response. Blarcamesine produces minimal effects on body weight gain in Mecp2 HET mice. Animal Model: Female Mecp2tm1.1Bird/J HET (C57 background) mice Dosage: 10 mg/kg, 30 mg/kg Administration: Oral administration, daily, for 6.5 weeks Result: Reverse the deficits observed in the HET animals.
参考文献: 1. Walter E Kaufmann, et al. ANAVEX®2-73 (Blarcamesine), a Sigma-1 Receptor Agonist, Ameliorates Neurologic Impairments in a Mouse Model of Rett Syndrome. Pharmacol Biochem Behav . 2019 Dec;187:172796.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.554 ml 17.769 ml 35.538 ml
5 mM 0.711 ml 3.554 ml 7.108 ml
10 mM 0.355 ml 1.777 ml 3.554 ml
50 mM 0.071 ml 0.355 ml 0.711 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×